Taken together, the observed reduction in airway eosinophilia by artesunate may be a result of combined inhibitory effects on IL-4, IL-5, IL-13, eotaxin and RANTES production, and on adhesion molecule expression, secondary to inhibition of PI3K/Akt. This evidence concerns the gene IL5 and Increased total eosinophil count.